Discontinued — last reported Q3 '25
West Pharmaceutical Services Finance Lease Liability Payment Due decreased by 11.9% to $5.20M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 18.2%, from $4.40M to $5.20M. This is a positive signal — lower values indicate better performance for this metric.
An increase suggests higher debt-like obligations, while a decrease indicates reduced reliance on financed assets.
This represents the total future cash outflows required to satisfy obligations under finance lease agreements. It reflec...
Standard across manufacturing peers; higher levels relative to revenue may indicate aggressive asset financing.
finance_lease_liability_payment_due| Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|
| Value | $3.60M | $3.40M | $4.40M | $5.40M | $5.90M | $5.20M |
| QoQ Change | — | -5.6% | +29.4% | +22.7% | +9.3% | -11.9% |
| YoY Change | — | — | — | +50.0% | +73.5% | +18.2% |